Form 4: Medpace Holdings President Jesse Geiger Executes Stock Options and Sells Shares

Medpace Holdings President Jesse Geiger exercised stock options and sold shares on March 4th and 5th, 2024, according to a Form 4 filing with the SEC.

Summary

• Jesse J. Geiger, President of Medpace Holdings, Inc., executed employee stock options and sold shares of common stock on March 4th and 5th, 2024.
• On March 4th, Geiger exercised options to acquire 22,321 shares at a price of $90.65 per share and sold 22,321 shares at a weighted average price of $403.03, ranging from $401.60 to $404.525.
• Following these transactions on March 4th, Geiger directly owned 3,824 shares of common stock.
• On March 5th, Geiger exercised options to acquire 17,679 shares at a price of $90.65 per share.
• Following these transactions on March 5th, Geiger directly owned 21,503 shares of common stock.
• The options vested in full on August 5, 2019, and the transactions were executed pursuant to a limit order placed during an open window period.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• The exercise of options and subsequent sale of shares is a common practice among executives to realize the value of their compensation.
• The timing of these transactions is often governed by company policies and legal restrictions, such as trading windows.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates